<SEC-DOCUMENT>0001609251-17-000002-index.html : 20170214 <SEC-HEADER>0001609251-17-000002.hdr.sgml : 20170214 <ACCEPTANCE-DATETIME>20170214151054 ACCESSION NUMBER: 0001609251-17-000002 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170214 DATE AS OF CHANGE: 20170214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Aviragen Therapeutics, Inc. CENTRAL INDEX KEY: 0000072444 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 591212264 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-31596 FILM NUMBER: 17607694 BUSINESS ADDRESS: STREET 1: 2500 NORTHWINDS PARKWAY, SUITE 100 CITY: ALPHARETTA STATE: 2Q ZIP: 30009 BUSINESS PHONE: 301-770-3099 MAIL ADDRESS: STREET 1: 2500 NORTHWINDS PARKWAY, SUITE 100 CITY: ALPHARETTA STATE: 2Q ZIP: 30009 FORMER COMPANY: FORMER CONFORMED NAME: Biota Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20121113 FORMER COMPANY: FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS DATE OF NAME CHANGE: 20100719 FORMER COMPANY: FORMER CONFORMED NAME: NABI BIOPHARMACEUTICALS DATE OF NAME CHANGE: 20020304 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Krensavage Asset Management, LLC CENTRAL INDEX KEY: 0001609251 IRS NUMBER: 262520930 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 130 EAST 59TH STREET STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-888-1582 MAIL ADDRESS: STREET 1: 130 EAST 59TH STREET STREET 2: 11TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13G <SEQUENCE>1 <FILENAME>AVIR_13G_02.10.17_Amend_1.txt <DESCRIPTION>KRENSABACE ASSET MGT AVIR FORM 13G 12.31.2016 <TEXT> Document 1 - file: AVIR_13G_02.10.17_Amend_1.txt
</DOCUMENT> </SEC-DOCUMENT>